Radical prostatectomy for high-risk prostate cancer

International Journal of Urology

Volumn 16, Issue 9, 2009, Pages 733-738

  Kawamorita, Naoki ^a   Saito, Seiichi ^b   Ishidoya, Shigeto ^a   Ito, Akihiro ^a   Saito, Hideo ^a   Kato, Masanori ^a   Arai, Yoichi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

High grade; High risk; Prostate cancer; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

AGED; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 70349251712     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2009.02352.x     Document Type: Article

References (27)

1. Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carrol PR. Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer. J. Urol. 2003 169 : 157 163.
2. Rioux-Leclerco NC, Chan DY, Epstein JI. Prediction of outcome after radical prostatectomy in men with organ-confined gleason score 8 to 10 adenocarcinoma. Urology 2002 60 : 666 669.
3. Scher D, Swindle PW, Scardino PT. National comprehensive cancer network guidelines for the management of prostate cancer. Urology 2003 61 : 14 24.
4. Heidenreich A, Bolla M, Joniau S, et al. Guidelines on prostate cancer. European Association of Urology, 2007 31 43.
5. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1000 consecutive patients. J. Urol. 2002 167 : 528 534.
6. D'Amico AV, Whittington R, Malkowicz SB et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998 280 : 969 974. (Pubitemid 28445094)
7. Lau WK, Bergstralh EJ, Blute ML, Slezak JM, Zinke H. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables. J. Urol. 2002 167 : 117 122.
8. Mian BM, Troncoso P, Okihara K et al. Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone. J. Urol. 2002 167 : 1675 1680.
9. Perrotti M, Rabbani F, Russo P, Solomon MC, Fair WR. Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors. Urology 1998 52 : 106 110.
10. Manoharan M, Bird VG, Kim SS, Civantos F, Soloway MS. Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of ≥8. BJU Int. 2003 92 : 539 544.
11. Epstein JI. Tumours of the prostate. In : John NE (ed.). Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. International Agency for Research on Cancer, Lyon, 2004 179 184.
12. Epstein JI. Tumours of the prostate. In : John NE (ed.). Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. International Agency for Research on Cancer, Lyon, 2004 161.
13. Paulson DF, Piserchia PV, Gardner W. Predictors of lymphatic spread in prostatic adenocarcinoma: uro-oncology research group study. J. Urol. 1980 123 : 697 699.
14. Partin AW, Lee BR, Carmichael M, Walsh PC, Epstein JI. Radical prostatectomy for high grade disease: a reevaluation 1994. J. Urol. 1994 151 : 1583 1586.
15. Sogani PC, Israel A, Lieberman PH, Lesser ML, Whitmore WF. Gleason grading of prostate cancer: a predictor of survival. Urology 1985 25 : 223 227.
16. Ohori M, Goad JR, Wheeler TM, Eastham JA, Thompson TC, Scardino PT. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J. Urol. 1994 152 : 1843 1849.
17. Oefelein MG, Smith ND, Grayhack JT, Schaeffer AJ, McVary KT. Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate. J. Urol. 1997 158 : 1460 1465.
18. Donohue JF, Bianco FJ, Kuroiwa K et al. Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading. J. Urol. 2006 176 : 991 996.
19. Freedland SJ, Partin AW, Humphyreys EB, Mangold LA, Walsh PC. Radical prostatectomy for clinical stage T3a disease. Cancer 2007 109 : 1273 1278.
20. Carver BS, Bianco FJ, Scardino PT, Eastham JA. Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer. J. Urol. 2006 176 : 564 568.
21. Zwergel U, Suttmann H, Schroeder T et al. Outcome of prostate cancer patients with initial PSA 20 ng/mL undergoing radical prostatectomy. Eur. Urol. 2007 52 : 1058 1065.
22. Brandli DW, Koch MO, Foster RS, Bihrle R, Gardner TA. Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/mL) and clinically localized prostate cancer after radical prostatectomy. BJU Int. 2003 92 : 19 23.
23. May M, Gunia S, Helke C et al. How far is the preoperative Kattan nomogram applicable for the prediction of recurrence after prostatectomy in patients presenting with PSA level of more than 20 ng/ml? Urol. Int. 2006 77 : 222 226.
24. Eastham J, Tokuda Y, Scardino P. Trends in radical prostatectomy. Int. J. Urol. 2009 16 : 151 160.
25. Yossepowitch O, Bjartell A, Eastham JA et al. Surgical margins in radical prostatectomy: outlining the problem and its long-term consequences. Eur. Urol. 2009 55 : 87 99.
26. Nayyar R, Kumar R, Kumar V, Jagannathan NR, Gupta NP, Hemal AK. Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer. BJU Int. 2009 103 : 1614 1620.
27. Xu J, Humphrey PA, Kibel AS et al. Resonance diffusion characteristics of histologically defined prostate cancer in humans. Magn. Reson. Med. 2009 61 : 842 850.